Tty Biopharm Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Tty Biopharm Company Limited with three other
companies in this sector in Taiwan:
Sinphar Pharmaceutical C O., Ltd.
sales of 2.19 billion Taiwanese Dollars [US$71.70 million]
of which 66%
Standard Chem. & Pharm. Co Ltd
(3.32 billion Taiwanese Dollars [US$108.87 million]
of which 66%
was Standard), and
Formosa Laboratories, Inc
(2.60 billion Taiwanese Dollars [US$85.12 million]
of which 100%
was Active Pharmaceutical Ingredient).
Tty Biopharm Company Limited reported sales of 3.20 billion Taiwanese Dollars (US$104.74 million)
December of 2015.
increase of 7.2%
versus 2014, when the company's sales were 2.98 billion Taiwanese Dollars.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Tty Biopharm Company Limited had sales
of 3.44 billion Taiwanese Dollars.
Sales of Other saw an increase
that was more than double the company's growth rate: sales were up
225.0% in 2015, from
3.67 million Taiwanese Dollars to 11.92 million Taiwanese Dollars.
Tty Biopharm Company Limited also saw significant increases in sales in
Anti-Cancer Drug (up 49.5% to 2.08 billion Taiwanese Dollars)
Anti-Infection Drug (up 36.2% to 310.06 million Taiwanese Dollars)
Not all segments of Tty Biopharm Company Limited experienced an increase in sales in 2015:
sales of Taipei Branch fell 66.5% to 206.57 million Taiwanese Dollars.
Tty Biopharm Company Limited also experienced decreases in sales in
Cardiovascular and Gastrointestinal Drug (down 8.6% to 513.65 million Taiwanese Dollars)
Mainland (down 60.3% to 70.57 million Taiwanese Dollars)